[1. Alwan W.H., Carter S.D., Bennett D., Edwards G.B.: Glycosaminoglycans in horses with osteoarthritis. Equine Vet J 1991, 23, 44–47.10.1111/j.2042-3306.1991.tb02712.x1901787]Search in Google Scholar
[2. Bai B., Li Y.: Combined detection of serum CTX-II and COMP concentrations in osteoarthritis model rabbits: an effective technique for early diagnosis and estimation of disease severity. J Orthopaedic Surg Res 2016, 11, 149.10.1186/s13018-016-0483-x512043627876074]Search in Google Scholar
[3. Barrachina L., Remacha A.R., Soler L., García N., Romero A., Vázquez F.J., Vitoria A., Álava M.Á., Lamprave F., Rodellar C.: Acute phase protein haptoglobin as inflammatory marker in serum and synovial fluid in an equine model of arthritis. Vet Immunol Immunopathol 2016, 182, 74–78.10.1016/j.vetimm.2016.10.00527863554]Search in Google Scholar
[4. Clegg P.D., Coughlan A.R., Riggs C.M., Carter S.D.: Matrix metalloproteinases 2 and 9 in equine synovial fluids. Equine Vet J 1997, 29, 343–348.10.1111/j.2042-3306.1997.tb03137.x9306059]Open DOISearch in Google Scholar
[5. de Bakker E., Stroobants V., VanDael F., Ryssen B.V., Meyer E.: Canine synovial fluid biomarkers for early detection and monitoring of osteoarthritis. Vet Rec 2017, 180, 328–329.10.1136/vr.10398228364073]Search in Google Scholar
[6. de Grauw J.C., van de Lest C.H.A., van Weeren P.R.: Inflammatory mediators and cartilage biomarkers in synovial fluid after a single inflammatory insult: a longitudinal experimental study. Arthritis Res Ther 2009, 11, R35.10.1186/ar2640268818019272138]Open DOISearch in Google Scholar
[7. Frisbie D.D., Al-Sobayil F., Billinghurst R.C., Kawcak C.E., McIlwraith C.W.: Changes in synovial fluid and serum biomarkers with exercise and early osteoarthritis in horses. Osteoarthritis Cartilage 2008, 16, 1196–1204.10.1016/j.joca.2008.03.00818442931]Search in Google Scholar
[8. Fuller C., Barr A.R., Sharif M., Dieppe P.: Cross-sectional comparison of synovial fluid biochemical markers in equine osteoarthritis and the correlation of these markers with articular cartilage damage. Osteoarthritis Cartilage 2001, 9, 49–55.10.1053/joca.2000.034911178947]Search in Google Scholar
[9. Garner B., Stoker A., Kuroki K., Evans R., Cook C.R., Cook J.: Using animal models in osteoarthritis biomarker research. J Knee Surg 2001, 24, 251–264.10.1055/s-0031-129736122303754]Open DOISearch in Google Scholar
[10. Gaudin P., Razakaboay M., Surla A., Berthier S., Fauconnier J., Morel F., Phelip X.: A study of metalloproteinases in fifty joint fluid specimens. Rev Rhumat 1997, 64, 375–381.]Search in Google Scholar
[11. Gendron C., Kashiwagi M., Lim N.H., Enghild J.J., Thøgersen I.B., Hughes C., Caterson B., Nagase H.: Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4. J Biol Chem 2007, 282, 18294–18306.10.1074/jbc.M70152320017430884]Search in Google Scholar
[12. Heinegård D., Saxne T.: The role of the cartilage matrix in osteoarthritis. Nature Rev Rheumatol 2001, 7, 50–56.10.1038/nrrheum.2010.19821119607]Search in Google Scholar
[13. Iwai K.: Diverse ubiquitin signaling in NF-κB activation. Trends Cell Biol 2012, 22, 355–364.10.1016/j.tcb.2012.04.00122543051]Open DOISearch in Google Scholar
[14. Jouglin M., Robert C., Valette J.P., Gavard F., Quintin-Colonna F., Denoix J.M.: Metalloproteinases and tumor necrosis factor-alpha activities in synovial fluids of horses: correlation with articular cartilage alterations. Vet Res 2000, 31, 507–515.10.1051/vetres:2000136]Open DOISearch in Google Scholar
[15. Kamarainen O.P., Solovieva S., Vehmas T., Luoma K., Riihimaki H., Ala-Kokko L., Mannikko M., Leino-Arjas P.: Common interleukin-6 promoter variants associate with the more severe forms of distal interphalangeal osteoarthritis. Arthritis Res Ther 2008, 10, R21.10.1186/ar2374237445818257935]Search in Google Scholar
[16. Kamm J.L., Nixon A.J., Witte T.H.: Cytokine and catabolic enzyme expression in synovium, synovial fluid, and articular cartilage of naturally osteoarthritic equine carpi. Equine Vet J 2010, 42, 693–699.10.1111/j.2042-3306.2010.00140.x418375521039798]Open DOISearch in Google Scholar
[17. Kapoor M., Martelpelletier J., Lajeunesse D., Pelletier J.P., Fahmi H.: Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Prog Modern Biomed 2014, 7, 33–42.10.1038/nrrheum.2010.19621119608]Search in Google Scholar
[18. Kozaci L.D., Buttle D.J., Hollander A.P.: Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures. Arthritis Rheumatol 1997, 40, 164–174.10.1002/art.17804001219008612]Search in Google Scholar
[19. Maldonado M., Nam J.: The role of changes in extracellular matrix of cartilage in the presence of inflammation on the pathology of osteoarthritis. Biomed Res Int 2013, 2013, 284873.10.1155/2013/284873377124624069595]Search in Google Scholar
[20. Marttinen P.H., Raulo S.M., Suominen M.M., Tulamo R.M.: Changes in MMP-2 and -9 activity and MMP-8 reactivity after amphotericin B induced synovitis and treatment with bufexamac. J Vet Med 2006, 53, 311–318.10.1111/j.1439-0442.2006.00837.x16901276]Search in Google Scholar
[21. Mokbel A.N., El Tookhy O.S., Shamaa A.A., Rashed L.A., Sabry D., El Sayed A.M.: Homing and reparative effect of intra-articular injection of autologus mesenchymal stem cells in osteoarthritic animal model. BMC Musculoskelet Disord 2011, 12, 259.10.1186/1471-2474-12-259323243822085445]Search in Google Scholar
[22. Sawaji Y., Hynes J., Vincent T., Saklatvala J.: Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage. Arthritis Rheum 2008, 58, 3498–3509.10.1002/art.2402518975307]Open DOISearch in Google Scholar
[23. Skioldebrand E., Ekman S., Mattsson Hulten L., Svala E., Bjorkman K., Lindahl A., Lundqvist A., Onnerfjord P., Sihlbom C., Ruetschi U.: Cartilage oligomeric matrix protein neoepitope in the synovial fluid of horses with acute lameness: A new biomarker for the early stages of osteoarthritis. Equine Vet J 2017, 49, 662–667.10.1111/evj.12666557394628097685]Search in Google Scholar
[24. Skioldebrand E., Heinegard D., Eloranta M.L., Nilsson G., Dudhia J., Sandgren B., Ekman S.: Enhanced concentration of COMP (cartilage oligomeric matrix protein) in osteochondral fractures from racing Thoroughbreds. J Orthop Res 2005, 23, 156–163.10.1016/j.orthres.2004.05.01315607888]Open DOISearch in Google Scholar
[25. Trumble T.N., Trotter G.W., Oxford J.R., McIlwraith C.W., Cammarata S., Goodnight J.L., Billinghurst R.C., Frisbie D.D.: Synovial fluid gelatinase concentrations and matrix metalloproteinase and cytokine expression in naturally occurring joint disease in horses. Am J Vet Res 2001, 62, 1467–1477.10.2460/ajvr.2001.62.146711560279]Open DOISearch in Google Scholar
[26. Boom R., Brama P.A., Geesje H., Kiers G.H., Groot K.J., Weeren P.R.: Assessment of the effects of age and joint disease on hydroxyproline and glycosaminoglycan concentrations in synovial fluid from the metacarpophalangeal joint of horses. Am J Vet Res 2004, 65, 296–302.10.2460/ajvr.2004.65.29615027675]Open DOISearch in Google Scholar
[27. Verma P., Dalal K.: ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis. J Cell Biochem 2011, 112, 3507–3514.10.1002/jcb.2329821815191]Search in Google Scholar
[28. Wang G., Li X., Jiang R., Li Y., Fan X., Zheng Y., Gao L.: Changes in synovial fluid inflammatory mediators and cartilage biomarkers after experimental acute equine synovitis. Bull Vet Inst Pulawy 2015, 59, 129–131.10.1515/bvip-2015-0019]Search in Google Scholar
[29. Zheng W., Zhang H., Jin Y., Wang Q., Chen L., Feng Z., Chen H., Wu Y.: Butein inhibits IL-1beta-induced inflammatory response in human osteoarthritis chondrocytes and slows the progression of osteoarthritis in mice. Int Immunopharmacol 2017, 42, 1–10.10.1016/j.intimp.2016.11.00927863298]Search in Google Scholar